Tag Archives: They

Roche, Novartis are revving up next-generation eye drugs, but are they true contenders?

Roche and Novartis are working hard on next-generation drugs for wet age-related macular degeneration, and they’re hoping to steal significant market share away from entrenched drugs. But analysts aren’t convinced the new candidates can do the job. The Swiss pharma giants each rolled out data over the weekend backing their candidates—faricimab from Roche and brolucizumab… Read More »

Step-Ups: Not As Simple As They Look

While it may sometimes be challenging to see immediately how some resistance exercises translate in real life, it certainly isn’t the case with step-ups. After all, we do some on an everyday basis simply climbing up stairs, don’t we? Yes. And no. Step-ups seem like a really simple exercise, but there are a couple of… Read More »